U.K. Regulator to Probe Roche's Acquisition of Spark Therapeutics
25 September 2019 - 4:54PM
Dow Jones News
By Kim Richters
The U.K. Competition and Markets Authority is reviewing Roche
Holding AG's (RO.EB) planned acquisition of Spark Therapeutics Inc.
(ONCE), the regulator said Wednesday.
Swiss pharmaceuticals company Roche announced plans to acquire
U.S.-based biotechnology company Sparks in February this year.
The authority is considering whether a merger would lead to a
substantial lessening of competition within the United Kingdom and
it seeks comments on the deal by Oct. 11, it said.
Write to Kim Richters at kim.richters@wsj.com
(END) Dow Jones Newswires
September 25, 2019 02:39 ET (06:39 GMT)
Copyright (c) 2019 Dow Jones & Company, Inc.
Roche (QX) (USOTC:RHHBY)
Historical Stock Chart
From Apr 2024 to May 2024
Roche (QX) (USOTC:RHHBY)
Historical Stock Chart
From May 2023 to May 2024